The Role of It in the Pharmaceutical Industry
Table of Contents
Table of Contents i
Introduction 1
1 Definition of The Pharmaceutical Industry 1
2 Environmental Analysis 2 2.1 Legal Issues 2 2.2 Political Issues 2 2.3 Economic Issues 2 2.4 Social Issues 2 2.5 Technological Issues 2
3 Forces of Competition 3
4 Value Chain 4 4.1 Discovery 4 4.2 Production Development 4 4.3 Manufacturing 4 4.4 Marketing 4
5 Role of Information Systems & Technology 4
6 GlaxoSmithKline 5
7 United Drug 6 7.1 Company Overview 6 7.2 Competitors 6 7.3 Technological innovation 6 7.4 Further analysis: 6
8 Astra Zeneca 7
Conclusions 8
References I
Introduction
For the purposes of this report, we will perform a detailed overview of the pharmaceutical industry, including defining the industry and its strategic forces, an environmental analysis, the forces of competition within the industry and value chain analysis as well the role of IS/IT in the industry. Four companies will be individually researched within that industry and this individual analysis will include financial information as well as industry market sources. A clear plan will also be outlined for further analysis on these companies.
Definition of The Pharmaceutical Industry
Today the pharmaceutical industry is a global organization, in the area of research and development of new drugs to combat serious illnesses and life-threatening diseases. Historically apothecaries prepared medicinal compounds, whereas, today universities and large-scale manufacturing developments, with advanced scientific and technology techniques, develop and manufacture new drugs.
The diseases of the last century were cholera, tuberculosis, typhoid fever, but the modern diseases of, cancer, brain degenerative-diseases, etc, demand stronger, medically advanced drugs to combat them. This level of research demands teams of highly organised, trained scientists working in laboratories, who
Table of Contents i
Introduction 1
1 Definition of The Pharmaceutical Industry 1
2 Environmental Analysis 2 2.1 Legal Issues 2 2.2 Political Issues 2 2.3 Economic Issues 2 2.4 Social Issues 2 2.5 Technological Issues 2
3 Forces of Competition 3
4 Value Chain 4 4.1 Discovery 4 4.2 Production Development 4 4.3 Manufacturing 4 4.4 Marketing 4
5 Role of Information Systems & Technology 4
6 GlaxoSmithKline 5
7 United Drug 6 7.1 Company Overview 6 7.2 Competitors 6 7.3 Technological innovation 6 7.4 Further analysis: 6
8 Astra Zeneca 7
Conclusions 8
References I
Introduction
For the purposes of this report, we will perform a detailed overview of the pharmaceutical industry, including defining the industry and its strategic forces, an environmental analysis, the forces of competition within the industry and value chain analysis as well the role of IS/IT in the industry. Four companies will be individually researched within that industry and this individual analysis will include financial information as well as industry market sources. A clear plan will also be outlined for further analysis on these companies.
Definition of The Pharmaceutical Industry
Today the pharmaceutical industry is a global organization, in the area of research and development of new drugs to combat serious illnesses and life-threatening diseases. Historically apothecaries prepared medicinal compounds, whereas, today universities and large-scale manufacturing developments, with advanced scientific and technology techniques, develop and manufacture new drugs.
The diseases of the last century were cholera, tuberculosis, typhoid fever, but the modern diseases of, cancer, brain degenerative-diseases, etc, demand stronger, medically advanced drugs to combat them. This level of research demands teams of highly organised, trained scientists working in laboratories, who
References: Websites: Daily Finance (2010) GlaxoSmithKline Plc Top Competitors [Online], Available from: http://www.dailyfinance.com/company/glaxosmithkline-plc/gsk/nys/top-competitors [accessed 25 October 2010] Hallam, K. and Larkin, C. (2010) Glaxo’s Avandia to be pulled in EU, Restricted in U.S. [Online], Available from: http://www.businessweek.com/news/2010-09-23/glaxo-s-avandia-to-be-pulled-in-eu-restricted-in-u-s-.html. [accessed 4 October 2010] Lewcock, A